Simulations Plus reports Q3 adjusted EPS 45c, consensus 25c

Reports Q3 revenue $20.4M, consensus $20.93M. “In the third quarter, our revenue grew by 10% in line with our preliminary revenue,” said Shawn O’Connor, Chief Executive Officer of Simulations Plus (SLP). “Our software revenue continued to perform well, increasing 6%, mainly driven by our ADMET Predictor software and modest growth in our GastroPlus and MonolixSuite software, partially offset by a decline in our QSP/QST biosimulations software.”